Cyclo-Oxygenase-2 Inhibitors and the Kidney

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Drug Safety

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/00002018-200225030-00003PMID 11945113
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes.

  2001cited by this paper
• Genetic deletion of COX-2 prevents increased renin expression in response to ACE inhibition.

  2001cited by this paper
• Intrarenal expression and distribution of cyclooxygenase isoforms in rats with experimental heart failure.

  2001cited by this paper
• Cyclooxygenase-1 and cyclooxygenase-2 expression in rat kidney and adrenal gland after stimulation with systemic lipopolysaccharide

  2001cited by this paper
• Induction of cyclooxygenase-2 in thick ascending limb cells by adrenalectomy.

  2001cited by this paper
• Cyclooxygenase-2 in the kidney.

  2000cited by this paper
• Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor.

  2000cited by this paper
• Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

  2000cited by this paper
• COX-2 and the kidneys.

  2000cited by this paper
• Chronic cyclooxygenase‐2 inhibition blunts low sodium‐stimulated renin without changing renal haemodynamics

  2000cited by this paper
• Renal changes induced by a cyclooxygenase-2 inhibitor during normal and low sodium intake.

  2000cited by this paper
• Basic biology and clinical application of specific cyclooxygenase-2 inhibitors.

  2000cited by this paper
• COX-2 and the kidneys.

  2000cited by this paper
• Effect of Cyclooxygenase-2 Inhibition on Renal Function in Elderly Persons Receiving a Low-Salt Diet

  2000cited by this paper
• A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats.

  2000cited by this paper
• Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice.

  2000cited by this paper
• Are selective COX-2 inhibitors nephrotoxic?

  2000cited by this paper
• NSAIDs: a Faustian bargain.

  2000cited by this paper
• Effects of celecoxib and naproxen on renal function in the elderly.

  2000cited by this paper
• Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.

  2000cited by this paper
• Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.

  1999cited by this paper
• Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites.

  1999cited by this paper
• Natriuretic response to increased pressure is preserved with COX-2 inhibitors.

  1999cited by this paper
• Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

  1999cited by this paper
• Renal effects of selective cyclooxygenase‐2 inhibition in normotensive salt‐depleted subjects

  1999cited by this paper
• Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive heymann nephritis in the rat.

  1999cited by this paper
• Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension.

  1999cited by this paper
• Upregulation of renal and systemic cyclooxygenase-2 in patients with active lupus nephritis.

  1998cited by this paper
• Selective increase of cyclooxygenase-2 expression in a model of renal ablation.

  1998cited by this paper
• Selective increase of cyclooxygenase-2 expression in a model of renal ablation.

  1998cited by this paper
• Regulation of cyclooxygenase expression in the kidney by dietary salt intake.

  1998cited by this paper
• Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet.

  1997cited by this paper
• An open study to assess the safety and tolerability of meloxicam 15 mg in subjects with rheumatic disease and mild renal impairment.

  1996cited by this paper
• Interference of corticosteroids with prostaglandin E2 synthesis at the level of cyclooxygenase-2 mRNA expression in kidney cells.

  1996cited by this paper
• Renal complications associated with use of nonsteroidal anti-inflammatory agents.

  1995cited by this paper
• Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction.

  1994cited by this paper
• Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs.

  1994cited by this paper
• The macula densa mechanism for control of renin secretion.

  1993cited by this paper
• Utilization of nonsteroidal antiinflammatory drugs.

  1985cited by this paper
• Incidence of hyperkalaemia induced by indomethacin in a hospital population.

  1985cited by this paper
• Nonsteroidal antiinflammatory drugs and renal function.

  1984cited by this paper
• Renal syndromes associated with nonsteroidal antiinflammatory drugs.

  1984cited by this paper
• Adverse effects of nonsteroidal anti-inflammatory drugs on the kidney.

  1984cited by this paper

• Nonsteroidal Antiinflammatory Drugs and Opioids in Chronic Kidney Disease

  2020cites this paper
• Attitude and Awareness of Dentists Practicing in Southern India Toward Non-steroidal Anti-inflammatory Drugs

  2019cites this paper
• Diclofenac-induced biochemical changes in nephrotoxicity among male Albino rats

  2018cites this paper
• Clinical Uses of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Potential Benefits of NSAIDs Modified-Release Preparations

  2017cites this paper
• Prostaglandin E2 Signaling Through Kidney EP1 and EP4 Receptors; Implications in Diabetes and Hypertension

  2015cites this paper
• Decyzje ekonomiczne w świetle etyki – studium przypadków

  2015cites this paper
• Non-Steroidal Anti-Inflammatory Drugs and Chronic Kidney Disease

  2015cites this paper
• Parecoxib reduces renal injury in an ischemia/reperfusion model in rats.

  2015cites this paper
• ISCHEMIA/REPERFUSION Parecoxib reduces renal injury in an ischemia/reperfusion model in rats 1

  2015cites this paper
• PTGER1 deletion attenuates renal injury in diabetic mouse models.

  2013cites this paper
• Valdecoxib

  2012cites this paper
• Hyperkalemia and Hypokalemia

  2011cites this paper
• The Role of Podocyte Prostaglandin E2 and Angiotensin II Receptors in Glomerular Disease

  2011cites this paper
• Nonsteroidal Anti-Inflammatory Drugs and the Kidney

  2010cites this paper
• The Podocyte in Diabetic Kidney Disease

  2009cites this paper
• Heterotopic Ossification Prophylaxis - The Hip

  2008cites this paper
• Heterotopic Ossifications: General Survey for All Sites

  2008cites this paper
• Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis.

  2006cites this paper
• Drug dosing in chronic kidney disease.

  2005cites this paper
• Inhibiteurs sélectifs de COX-2 : quelle toxicité gastro-duodénale ?

  2004cites this paper
• Cardiovascular complications of COX2 selective inhibitors cause considerable concern

  2004cites this paper
• [Coxibs, which real therapeutic advance?: Recent pharmacoepidemiological data].

  2004cites this paper
• [Selective COX-2 inhibitors: do they retain any gastroduodenal toxicity].

  2004cites this paper
• COX-2 inhibitors: a CLASS act or Just VIGORously promoted.

  2004cites this paper
• Lithium Intoxication as a Result of an Interaction with Rofecoxib

  2004cites this paper
• Coxibs, quel réel progrès thérapeutique ? : données pharmacoépidémiologiques récentes

  2004cites this paper
• The treatment of patients with advanced renal involvement

  2003cites this paper
• Hypertension in the patient with arthritis: have we been underestimating its significance?

  2003cites this paper
• Rofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects

  2003cites this paper
• Effects of NSAIDs on the Incidence of Hospitalisations for Renal Dysfunction in Users of ACE Inhibitors

  2003cites this paper
• Renal Failure Associated with the Use of Celecoxib and Rofecoxib

  2002cites this paper
• Pharmacoepidemiology and drug safety.

  2002cites this paper